v3.26.3
Consolidated Balance Sheets - USD ($)
Sep. 30, 2026
Dec. 31, 2025
Assets    
Loans receivable, net of deferred origination and other fees $ 59,478,735 $ 60,218,841
Interest and other fees receivable on loans 1,566,838 1,642,825
Cash 168,093 204,889
Cash – restricted 8,750 23,350
Other assets 88,508 60,742
Right-of-use asset – operating lease, net 61,616 101,226
Deferred financing costs, net 107,000 98,858
Total assets 61,479,540 62,350,731
Liabilities:    
Lines of credit 17,034,621 17,601,132
Accounts payable and accrued expenses 170,734 173,247
Operating lease liability 69,274 112,076
Loan holdback 164,598 50,000
Dividends payable 1,250,834 1,314,732
Total liabilities 18,690,061 19,251,187
Stockholders’ equity:    
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,377,466 and 11,432,451 outstanding, respectively 11,757 11,757
Additional paid-in capital 45,583,716 45,575,006
Less: Treasury shares, at cost – 379,592 and 324,607 shares, respectively (1,318,303) (1,098,964)
Accumulated deficit (1,487,691) (1,388,255)
Total stockholders’ equity 42,789,479 43,099,544
Total liabilities and stockholders’ equity $ 61,479,540 $ 62,350,731